Magle Chemoswed Holding AB (publ) (STO:MAGLE)
22.40
-0.20 (-0.88%)
Sep 2, 2025, 2:14 PM CET
STO:MAGLE Revenue
Magle Chemoswed Holding AB had revenue of 53.69M SEK in the quarter ending June 30, 2025, with 16.10% growth. This brings the company's revenue in the last twelve months to 292.32M, up 63.20% year-over-year. In the year 2024, Magle Chemoswed Holding AB had annual revenue of 240.57M with 40.27% growth.
Revenue (ttm)
292.32M
Revenue Growth
+63.20%
P/S Ratio
1.57
Revenue / Employee
1.85M
Employees
147
Market Cap
459.56M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 240.57M | 69.07M | 40.27% |
Dec 31, 2023 | 171.50M | 23.51M | 15.89% |
Dec 31, 2022 | 147.98M | 15.84M | 11.98% |
Dec 31, 2021 | 132.15M | -10.19M | -7.16% |
Dec 31, 2020 | 142.34M | 10.55M | 8.01% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |